- Home
- Publications
- Publication Search
- Publication Details
Title
Multi-Omics Technologies Applied to Tuberculosis Drug Discovery
Authors
Keywords
-
Journal
Applied Sciences-Basel
Volume 10, Issue 13, Pages 4629
Publisher
MDPI AG
Online
2020-07-06
DOI
10.3390/app10134629
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insight about cell wall remodulation triggered by rifampicin in Mycobacterium tuberculosis
- (2020) Jean Eduardo Meneguello et al. TUBERCULOSIS
- Discovery of a novel dehydratase of the fatty acid synthase type II critical for ketomycolic acid biosynthesis and virulence of Mycobacterium tuberculosis
- (2020) Cyril Lefebvre et al. Scientific Reports
- New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis
- (2020) Andréanne Lupien et al. PLoS Pathogens
- Photoactivatable Glycolipid Probes for Identifying Mycolate–Protein Interactions in Live Mycobacteria
- (2020) Herbert W. Kavunja et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- New tuberculosis drug targets, their inhibitors, and potential therapeutic impact
- (2020) Gauri S. Shetye et al. Translational Research
- Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence
- (2019) Noton K. Dutta et al. Science Advances
- More Is Not Always Better: Evaluation of 1D and 2D-LC-MS/MS Methods for Metaproteomics
- (2019) Tjorven Hinzke et al. Frontiers in Microbiology
- Transcriptional profiling of a laboratory and clinical Mycobacterium tuberculosis strain suggests respiratory poisoning upon exposure to delamanid
- (2019) Van den Bossche An et al. TUBERCULOSIS
- Large-scale chemical–genetics yields new M. tuberculosis inhibitor classes
- (2019) Eachan O. Johnson et al. NATURE
- Systems Biology and Multi-Omics Integration: Viewpoints from the Metabolomics Research Community
- (2019) Farhana R. Pinu et al. Metabolites
- Mycobacterium tuberculosis requires glyoxylate shunt and reverse methylcitrate cycle for lactate and pyruvate metabolism
- (2019) Agnese Serafini et al. MOLECULAR MICROBIOLOGY
- Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline
- (2019) Zhe Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tuberculosis drug discovery in the CRISPR era
- (2019) Jeremy Rock PLoS Pathogens
- Lipidomic insights to understand membrane dynamics in response to vanillin in Mycobacterium smegmatis
- (2019) Sharda Sharma et al. INTERNATIONAL MICROBIOLOGY
- Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis
- (2019) Shuyi Ma et al. mBio
- Making multi-omics data accessible to researchers
- (2019) Ana Conesa et al. Scientific Data
- Vertical and horizontal integration of multi-omics data with miodin
- (2019) Benjamin Ulfenborg BMC BIOINFORMATICS
- Intracellular Mycobacterium tuberculosis Exploits Multiple Host Nitrogen Sources during Growth in Human Macrophages
- (2019) Khushboo Borah et al. Cell Reports
- Accelerating Early Antituberculosis Drug Discovery by Creating Mycobacterial Indicator Strains That Predict Mode of Action
- (2018) Maikel Boot et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter
- (2018) Huiqing Zheng et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds
- (2018) Mattia Zampieri et al. Science Translational Medicine
- Proteomic analysis reveals that sulfamethoxazole induces oxidative stress in M. tuberculosis
- (2018) R. Sarkar et al. TUBERCULOSIS
- HadD, a novel fatty acid synthase type II protein, is essential for alpha- and epoxy-mycolic acid biosynthesis and mycobacterial fitness
- (2018) Cyril Lefebvre et al. Scientific Reports
- Untargeted metabolomics reveals a new mode of action of pretomanid (PA-824)
- (2018) Rafael Baptista et al. Scientific Reports
- Mycobacterium tuberculosis H37Rv reveal differential proteome during intracellular survival within alveolar epithelial cells as compared to macrophages
- (2018) S Agarwal et al. Pathogens and Disease
- The Expanding Diversity of Mycobacterium tuberculosis Drug Targets
- (2018) Samantha Wellington et al. ACS Infectious Diseases
- Quantitative N-Terminal Footprinting of Pathogenic Mycobacteria Reveals Differential Protein Acetylation
- (2018) Cristal Reyna Thompson et al. JOURNAL OF PROTEOME RESEARCH
- Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Mycobacterium tuberculosis carrying a rifampicin drug resistance mutation reprograms macrophage metabolism through cell wall lipid changes
- (2018) Nicole C. Howard et al. Nature Microbiology
- No Evidence for Acquired Mutations Associated with Cytochrome bc1 Inhibitor Resistance in 13,559 Clinical Mycobacterium tuberculosis Complex Isolates
- (2018) Jan Rybniker et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Arylvinylpiperazine Amides, a New Class of Potent Inhibitors Targeting QcrB of Mycobacterium tuberculosis
- (2018) Caroline S. Foo et al. mBio
- Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis
- (2017) Michael A. DeJesus et al. mBio
- Systematic, multiparametric analysis of Mycobacterium tuberculosis intracellular infection offers insight into coordinated virulence
- (2017) Amy K. Barczak et al. PLoS Pathogens
- Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform
- (2017) Jeremy M. Rock et al. Nature Microbiology
- Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane
- (2017) Laura Chiaradia et al. Scientific Reports
- Bedaquiline Targets the ε Subunit of Mycobacterial F-ATP Synthase
- (2016) Subhashri Kundu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mutations inpepQConfer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis
- (2016) Deepak Almeida et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3
- (2016) Wei Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy
- (2016) Isobella Honeyborne et al. BMC Medicine
- Unexpected high prevalence of resistance-associatedRv0678variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline
- (2016) Cristina Villellas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in Mycobacterium tuberculosis
- (2016) Eliza J. R. Peterson et al. Nature Microbiology
- Comprehensive insights into transcriptional adaptation of intracellular mycobacteria by microbe-enriched dual RNA sequencing
- (2015) Rienk A Rienksma et al. BMC GENOMICS
- Teixobactin, the first of a new class of antibiotics discovered by iChip technology?
- (2015) Laura J. V. Piddock JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Transcriptional Adaptation of Drug-tolerantMycobacterium tuberculosisDuring Treatment of Human Tuberculosis
- (2015) Nicholas D. Walter et al. JOURNAL OF INFECTIOUS DISEASES
- A new antibiotic kills pathogens without detectable resistance
- (2015) Losee L. Ling et al. NATURE
- Nano-LC in proteomics: recent advances and approaches
- (2015) Steven Ray Wilson et al. Bioanalysis
- Lansoprazole is an antituberculous prodrug targeting cytochrome bc1
- (2015) Jan Rybniker et al. Nature Communications
- Genetic Approaches to Facilitate Antibacterial Drug Development
- (2015) Dirk Schnappinger Cold Spring Harbor Perspectives in Medicine
- Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
- (2014) R. C. Hartkoorn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ultra-performance liquid chromatography–mass spectrometry as a sensitive and powerful technology in lipidomic applications
- (2014) Ying-Yong Zhao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Crystal Structure of the Transcriptional Regulator Rv0678 ofMycobacterium tuberculosis
- (2014) Abhijith Radhakrishnan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Isobaric Labeling-Based Relative Quantification in Shotgun Proteomics
- (2014) Navin Rauniyar et al. JOURNAL OF PROTEOME RESEARCH
- GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
- (2014) Shengdar Q Tsai et al. NATURE BIOTECHNOLOGY
- Genomic insights into tuberculosis
- (2014) James E. Galagan NATURE REVIEWS GENETICS
- Potassium availability triggers Mycobacterium tuberculosis transition to, and resuscitation from, non-culturable (dormant) states
- (2014) E. G. Salina et al. Open Biology
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
- (2013) Lei S. Qi et al. CELL
- Proteomic Profiling ofMycobacterium tuberculosisIdentifies Nutrient-starvation-responsive Toxin–antitoxin Systems
- (2013) Jakob Albrethsen et al. MOLECULAR & CELLULAR PROTEOMICS
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Function Prediction and Analysis of Mycobacterium tuberculosis Hypothetical Proteins
- (2012) Gaston K. Mazandu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
- (2012) Christine Vogel et al. NATURE REVIEWS GENETICS
- Precise Null Deletion Mutations of the Mycothiol Synthesis Genes Reveal Their Role in Isoniazid and Ethionamide Resistance in Mycobacterium smegmatis
- (2011) Xia Xu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Coresistance to Isoniazid and Ethionamide Maps to Mycothiol Biosynthetic Genes in Mycobacterium bovis
- (2011) Catherine Vilchèze et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of membrane proteins of Mycobacterium tuberculosis H37Rv and H37Ra strains
- (2011) Hiwa Målen et al. BMC MICROBIOLOGY
- Mycobacterial P1-Type ATPases Mediate Resistance to Zinc Poisoning in Human Macrophages
- (2011) Hélène Botella et al. Cell Host & Microbe
- Lipidomics: New Tools and Applications
- (2010) Markus R. Wenk CELL
- Metabolomics of Mycobacterium tuberculosis Reveals Compartmentalized Co-Catabolism of Carbon Substrates
- (2010) Luiz Pedro S. de Carvalho et al. CHEMISTRY & BIOLOGY
- Microarray Analysis of the Chelerythrine-Induced Transcriptome of Mycobacterium tuberculosis
- (2010) Junchao Liang et al. CURRENT MICROBIOLOGY
- Portrait of a Pathogen: The Mycobacterium tuberculosis Proteome In Vivo
- (2010) Nicole A. Kruh et al. PLoS One
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
- (2010) Kevin Pethe et al. Nature Communications
- Mass spectrometry: from proteomics to metabolomics and lipidomics
- (2009) William J. Griffiths et al. CHEMICAL SOCIETY REVIEWS
- To catch a killer. What can mycobacterial models teach us about Mycobacterium tuberculosis pathogenesis?
- (2009) Michael U Shiloh et al. CURRENT OPINION IN MICROBIOLOGY
- Genomic Diversity among Drug Sensitive and Multidrug Resistant Isolates of Mycobacterium tuberculosis with Identical DNA Fingerprints
- (2009) Stefan Niemann et al. PLoS One
- Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
- (2009) V. Makarov et al. SCIENCE
- Structural biology of the purine biosynthetic pathway
- (2008) Y. Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Biosynthesis and Functions of Mycothiol, the Unique Protective Thiol of Actinobacteria
- (2008) G. L. Newton et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Mycothiol biosynthesis is essential for ethionamide susceptibility inMycobacterium tuberculosis
- (2008) Catherine Vilchèze et al. MOLECULAR MICROBIOLOGY
- The Enduring Hypoxic Response of Mycobacterium tuberculosis
- (2008) Tige R. Rustad et al. PLoS One
- Probing Host Pathogen Cross-Talk by Transcriptional Profiling of Both Mycobacterium tuberculosis and Infected Human Dendritic Cells and Macrophages
- (2008) Ludovic Tailleux et al. PLoS One
- PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
- (2008) R. Singh et al. SCIENCE
- Cytological and Transcript Analyses Reveal Fat and Lazy Persister-Like Bacilli in Tuberculous Sputum
- (2008) Natalie J Garton et al. PLOS MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now